685 US HIGHWAY ONE, NORTH BRUNSWICK, NJ
Investor Presentation
Secures Up to $50 Million Senior Secured Term Loan Facility from Horizon Technology Finance
Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice
Expands Board of Directors with the Appointment of Andrew Einhorn
Pelthos Therapeutics Inc. 2025 Annual Meeting Vote Results
Annual Report to Security Holders
Announces Third Quarter Fiscal 2025 Financial Results
FY 2025
Q3
Q2
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Amended Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Definitive Merger Information Statement